APWM
MRNA icon

Atlas Private Wealth Management’s Moderna MRNA Stock Holding History

Atlas Private Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-75
Closed -$10K – 272
2021
Q1 		$10K Hold
75
– – 0.01% 312
2020
Q4 		$8K Hold
75
– – 0.01% 326
2020
Q3 		$5K Sell
75
-50
-40% -$3.49K ﹤0.01% 353
2020
Q2 		$8K Buy
+125
New +$6.85K 0.01% 347

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Atlas Private Wealth Management's MRNA Position: Q2 2021 in Review

Atlas Private Wealth Management sold out of Moderna (MRNA) in Q2 2021, closing a stake of 75 shares — an estimated $10K sold.

Atlas Private Wealth Management first reported a position in MRNA in Q2 2020 and held it in 4 quarters. The position peaked at $10K in Q1 2021. 903 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

  • Atlas Private Wealth Management reported no remaining Moderna position as of Q2 2021 after selling out during the quarter.
  • Atlas Private Wealth Management sold 75 Moderna shares in Q2 2021, an estimated $10K.
  • Atlas Private Wealth Management first reported a position in Moderna in Q2 2020 and held it in 4 quarters.
  • Atlas Private Wealth Management's Moderna position peaked at $10K in Q1 2021.
  • 903 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on Atlas Private Wealth Management's 13F filing for Q2 2021, filed 5 Aug 2021.